Eva
Bandres Elizalde
To 2004
Hospital Universitario Reina Sofia
Córdoba, España
Publications in collaboration with researchers from Hospital Universitario Reina Sofia (7)
2023
-
“Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain”
Human Immunology, Vol. 84, Núm. 4, pp. 290-295
2011
-
Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan
Pharmacogenomics Journal, Vol. 11, Núm. 6, pp. 429-436
2009
-
Epigenetic regulation of microRNA expression in colorectal cancer
International Journal of Cancer, Vol. 125, Núm. 11, pp. 2737-2743
-
Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia
Cancer Research, Vol. 69, Núm. 10, pp. 4443-4453
2008
-
Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth
Molecular Cancer Research, Vol. 6, Núm. 12, pp. 1830-1840
2007
-
GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment
Current Drug Metabolism, Vol. 8, Núm. 5, pp. 481-486
2006
-
Potential application of GSTT1-null genotype in predicting toxicity associated to 5-fluouracil irinotecan and leucovorin regimen in advanced stage colorectal cancer patients
Oncology Reports, Vol. 16, Núm. 3, pp. 497-503